Cetera Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Cetera Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Hold	330	–	–	0.01%	259
2026 Q1	$20K	Hold	330	–	–	0.01%	255
2025 Q4	$17.8K	Hold	330	–	–	0.01%	259
2025 Q3	$14.9K	Hold	330	–	–	0.01%	265
2025 Q2	$15.3K	Hold	330	–	–	0.01%	262
2025 Q1	$20.1K	Sell	330 -1,550	-82%	-$90.3K	0.01%	252
2024 Q4	$106K	Sell	1,880 -88	-4%	-$4.92K	0.07%	195
2024 Q3	$102K	Sell	1,968 -15,959	-89%	-$749K	0.06%	205
2024 Q2	$745K	Sell	17,927 -2,165	-11%	-$96.9K	0.47%	50
2024 Q1	$1.09M	Buy	20,092 +2,325	+13%	+$118K	0.66%	42
2023 Q4	$912K	Buy	+17,767	New	+$933K	0.57%	44

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cetera Trust Company's BMY Position: Q2 2026 in Review

Cetera Trust Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 330 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #259.

Cetera Trust Company first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.09M in Q1 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cetera Trust Company held 330 shares of Bristol-Myers Squibb worth $19K as of Q2 2026.
Cetera Trust Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Cetera Trust Company's portfolio in Q2 2026, its #259 holding.
Cetera Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Cetera Trust Company's Bristol-Myers Squibb position peaked at $1.09M in Q1 2024.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.